Improving Function Through Primary Care Treatment of PTSD (PE-PC)
Posttraumatic Stress Disorder
About this trial
This is an interventional treatment trial for Posttraumatic Stress Disorder focused on measuring posttraumatic stress disorder
Eligibility Criteria
Inclusion Criteria:
- Any era Veterans seeking care in VA PC for PTSD symptoms (PCL-5 28) and PTSD confirmed based on CAPS
- English speaking
- Report significant impairment in function related to PTSD symptoms as noted on intake WHODAS
- Report that they want treatment for PTSD
- If individuals are taking psychotropic medication, 2-weeks on stable dose will be required prior to enrollment
Exclusion Criteria:
- Other primary clinical issue that would interfere with PTSD treatment
Level of suicidal risk as determined by the Columbia Suicide Severity Rating Scale (C-SSRS (46)) that requires:
- PTSD + interested and consent to study
PCP Screen:
- PC-PTSD + Intake
PCMHI Provider:
[PCL 28] + brief interview
- No PTSD OR
- Not interested in treatment OR
- Not interested in study
- Severe cognitive impairment that, in the judgment of the investigator, makes it unlikely that the patient can adhere to the study regimen
- Psychosis or unmanaged bipolar disorder
- Moderate to severe substance use disorder in the past 8 weeks
- Patients who are currently receiving talk therapy for trauma-related symptoms
Sites / Locations
- Atlanta VA Medical and Rehab Center, Decatur, GA
- Ralph H. Johnson VA Medical Center, Charleston, SC
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Prolonged Exposure for Primary Care (PE-PC)
Treatment as Usual (TAU)
Brief version of PE provided in 30 minute sessions in PC
Veterans assigned to PCMHI-TAU will receive standard PCMHI care for PTSD in PC that does not include any PTSD-specific therapy in PCMHI but may include referral for specialty care (including specialty MH), medication management or general supportive contact while awaiting referral. All PTSD care received during the study will be collected and monitored as TAU.